madman
Super Moderator
Another powerhouse in the field!
* He presents compelling data showing that Testosterone Replacement Therapy (TRT), when bringing levels back to the normal range, can significantly reduce all-cause and cardiovascular death rates, improve quality of life, reduce insulin resistance (the core defect in diabetes), and even improve cognitive function, advocating for its wider adoption in clinical practice as a "health hormone."
Hugh Jones's presentation at the Longevity Forum Science Summit delves into the strong, often overlooked, association between low testosterone in men and increased cardiovascular mortality and chronic health issues. Drawing on research from Sheffield and other international studies, Dr. Jones highlights that low testosterone is not simply an aging factor but is highly correlated with functional hypogonadism caused by co-morbidities like Type 2 diabetes, obesity, and metabolic syndrome. He presents compelling data showing that Testosterone Replacement Therapy (TRT), when bringing levels back to the normal range, can significantly reduce all-cause and cardiovascular death rates, improve quality of life, reduce insulin resistance (the core defect in diabetes), and even improve cognitive function, advocating for its wider adoption in clinical practice as a "health hormone."
www.nebido.com
SCREENING FOR HYPOGONADISM. Who should be screened? The importance of sexual symptoms (2021)
Speakers
Professor T. Hugh Jones
Centre for Diabetes & Endocrinology,
Barnsley Hospital NHS Foundation Trust &
Academic Unit of Diabetes,
Endocrinology & Metabolism,
University of Sheffield, UK
In the fourth of our 2022 ABCD webinar series, please join Dr. Bob Ryder and Professor Hugh Jones to discuss symptomatic testosterone deficiency.
40% of men with type 2 diabetes have symptomatic testosterone deficiency. Testosterone deficiency is associated with an adverse effect on cardiovascular...
www.healio.com
An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men but may also provide cardiometabolic benefits.
Nearly 20 years ago, researchers discovered a link between low testosterone in men and the prevalence of diabetes. In a study published in 2004, researchers analyzed blood samples from 103 men with type 2 diabetes and discovered one-third of the cohort had...
* He presents compelling data showing that Testosterone Replacement Therapy (TRT), when bringing levels back to the normal range, can significantly reduce all-cause and cardiovascular death rates, improve quality of life, reduce insulin resistance (the core defect in diabetes), and even improve cognitive function, advocating for its wider adoption in clinical practice as a "health hormone."
Hugh Jones's presentation at the Longevity Forum Science Summit delves into the strong, often overlooked, association between low testosterone in men and increased cardiovascular mortality and chronic health issues. Drawing on research from Sheffield and other international studies, Dr. Jones highlights that low testosterone is not simply an aging factor but is highly correlated with functional hypogonadism caused by co-morbidities like Type 2 diabetes, obesity, and metabolic syndrome. He presents compelling data showing that Testosterone Replacement Therapy (TRT), when bringing levels back to the normal range, can significantly reduce all-cause and cardiovascular death rates, improve quality of life, reduce insulin resistance (the core defect in diabetes), and even improve cognitive function, advocating for its wider adoption in clinical practice as a "health hormone."
ESSM 2021 Symposium sa Prof Hugh Jones
SCREENING FOR HYPOGONADISM. Who should be screened? The importance of sexual symptoms (2021)
Speakers
Professor T. Hugh Jones
Centre for Diabetes & Endocrinology,
Barnsley Hospital NHS Foundation Trust &
Academic Unit of Diabetes,
Endocrinology & Metabolism,
University of Sheffield, UK
On-Demand webinar: 40% of men with type 2 diabetes have symptomatic testosterone deficiency – why are we still not finding and treating these men?
In the fourth of our 2022 ABCD webinar series, please join Dr. Bob Ryder and Professor Hugh Jones to discuss symptomatic testosterone deficiency.
40% of men with type 2 diabetes have symptomatic testosterone deficiency. Testosterone deficiency is associated with an adverse effect on cardiovascular...
Testosterone therapy may benefit men with diabetes and obesity, but remains controversial
Endocrine Today | An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men, but may also provide cardiometabolic benefits. Nearly 20 years ago, researchers discovered a link between low testosterone in men and the prevalence of...
www.healio.com
An increasing number of studies are reporting that testosterone therapy may not only normalize testosterone levels for men but may also provide cardiometabolic benefits.
Nearly 20 years ago, researchers discovered a link between low testosterone in men and the prevalence of diabetes. In a study published in 2004, researchers analyzed blood samples from 103 men with type 2 diabetes and discovered one-third of the cohort had...
